BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

by · The Cerbat Gem

BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) saw a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 8,100 shares, a growth of 710.0% from the September 15th total of 1,000 shares. Based on an average trading volume of 5,400 shares, the short-interest ratio is presently 1.5 days.

BioNxt Solutions Stock Performance

Shares of OTCMKTS BNXTF remained flat at $0.18 during midday trading on Thursday. The company has a market cap of $20.34 million, a P/E ratio of -3.60 and a beta of 0.85. BioNxt Solutions has a 1-year low of $0.00 and a 1-year high of $0.57. The stock has a fifty day moving average price of $0.17 and a 200 day moving average price of $0.23.

BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last announced its quarterly earnings results on Wednesday, August 28th. The company reported ($0.01) EPS for the quarter.

About BioNxt Solutions

(Get Free Report)

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.

Further Reading